Integrating complementary and conventional medicine

Cancer Forum

Volumn 35, Issue 1, 2011, Pages 31-39

  Pirri, Carlo ^a  

^a MURDOCH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPATHY; ALTERNATIVE MEDICINE; DIET SUPPLEMENTATION; EVIDENCE BASED MEDICINE; HOLISTIC CARE; QUALITY OF LIFE; REVIEW;

EID: 79955052103     PISSN: 0311306X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. National Center for Complementary and Alternative Medicine (NCCAM) [Internet]. CAM basics: what is CAM? Bethesda: NCCAM; 2009 [cited 2009 July 28]. Available from: http://nccam.nih.gov/health/whatiscam/D347.pdf
2. Cassileth BR. Complementary and alternative cancer medicine. J Clin Oncol. 1999;17:44-52. (Pubitemid 29519677)
3. Cancer Council New South Wales (NSW). Understanding complementary therapies: a guide for people with cancer, their families and friends. 2nd ed. Woolloomooloo: Cancer Council NSW; 2009. 117 p.
4. Deng G, Cassileth BR, Yeung KS. Complementary therapies for cancer-related symptoms. J Support Oncol. 2004;2:419-26.
5. Cassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist. 2004; 9(1):80-9.
6. Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol. 2009;7(3):85-120.
7. National Prescribing Service (NPS) [Internet]. NPS National consumer survey no. 5. Sydney: NPS; 2005 [cited 2010 Jan 22]. Available from: http://www.nps.org.au/-data/assets/pdf-file/0009/26874/cons-survey-5-exec.pdf
8. Australian Bureau of Statistics (ABS) [Internet]. Australian Social Trends 1998. Canberra: ABS; 1998 [cited 2009 Jul 28]. Available from: http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4102.01998?OpenDocument.
9. Xue CC, Zhang AL, Lin V, Da Costa C, Story DF. Complementary and alternative medicine use in Australia: a national population-based survey. J Atern Complement Med. 2007;13(6):643-50. (Pubitemid 47357086)
10. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer. Cancer. 1998;83:777-82.
11. Yates JS, Mustian KM, Morrow GR, Gillies LJ, Padmanaban D, Atkins JN, Issell B, Kirshner JJ, Colman LK. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer. 2005;13(10):806-11.
12. Datamonitor [Internet]. Complementary and alternative medicines in cancer. Publication BFHC0462. New York: Datamonitor; 2002 Jun 30 [cited 2010 Jan 22]. Available from: http://tinyurl.com/39jad78.
13. Sibbritt D, Adams J, Easthope G, Young A. Complementary and alternative medicine (CAM) use among elderly Australian women who have cancer. Support Care Cancer. 2003;11(8):548-50. (Pubitemid 36994439)
14. Oh B, Butow P, Mullan B, Clarke S, Tattersall M, Boyer M, Beale P, Vardy J, Pavlakis N, Larke L. Patient-doctor communication: use of complementary and alternative medicine by adult patients with cancer. J Soc Integr Oncol. 2010;8(2):56-64.
15. Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655-63. (Pubitemid 40613334)
16. Pirri C, Katris P, Trotter J, Bayliss E, Bennett R, Drummond P. Use of complementary and alternative therapies by Australian cancer patients. Asia-Pacific J Clin Oncol. 2008;4(3):161-9.
17. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999;340:1733-9. (Pubitemid 29252602)
18. Girgis A, Adams J, Sibbritt D. The use of complementary and alternative therapies by patients with cancer. Oncol Res. 2005;15:281-9. (Pubitemid 41415106)
19. Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review, Integr Cancer Ther. 2005;4(4):274-86. (Pubitemid 41698176)
20. Begbie SD, Kerestes ZL, Bell DR. Patterns of alternative medicine use by cancer patients. Med J Aust. 1996;165(10):545-8. (Pubitemid 26395048)
21. Miller M, Boyer MJ, Butow PN, Gattellari M, Dunn SM, Childs A. The use of unproven methods of treatment by cancer patients: frequency, expectations and cost. Support Care Cancer. 1998;6:337-47. (Pubitemid 28337124)
22. Yates PM, Beadle G, Clavarino A, Najman JM, Thomson D, Williams G, et al. Patients with terminal cancer who use alternative therapies: their beliefs and practices. Sociol Health Illn. 1993;15(2):199-216.
23. Sawyer MG, Gannoni AF, Toogood IR, Antoniou G, Rice M. The use of alternative therapies by children with cancer. Med J Aust. 1994;160:320-2. (Pubitemid 24090123)
24. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13):2505-14. (Pubitemid 30432515)
25. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol. 2000;18(13):2515-21. (Pubitemid 30432516)
26. Correa-Velez I, Clavarino A, Barnett AG, Eastwood H. Use of complementary and alternative medicine and quality of life: changes at the end of life. Palliat Med. 2003;17(8):695-703. (Pubitemid 37508954)
27. Correa-Velez I, Clavarino A, Eastwood H. Surviving, relieving, repairing, and boosting up: reasons for using complementary/ alternative medicine among patients with advanced cancer: a thematic analysis. Palliat Med. 2005;8(5):953-61.
28. Boon H, Brown JB, Gavin A, Kennard MA, Stewart M. Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use. Qual Health Res. 1999;9(5):639-53.
29. Sparber A, Bauer L, Curt G, Eisenberg D, Levin T, Parks S, et al. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum. 2000;27(4):623-30.
30. Shen J, Andersen R, Albert PS, Wenger N, Glaspy J, Cole M, et al. Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med. 2002;2:8.
31. Harris P, Finlay IG, Cook A, Thomas KJ, Hood K. Complementary and alternative medicine use by patients with cancer in Wales: a cross sectional survey, Complement Ther Med. 2003;11(4):249-53. (Pubitemid 38292337)
32. Scott JA, Kearney N, Hummerston S, Molassiotis A. Use of complementary and alternative medicine in patients with cancer: a UK survey. Eur J Oncol Nurs. 2005;9(2):131-7. (Pubitemid 40790434)
33. Singh H, Maskarinec G, Shumay DM. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer. Integr Cancer Ther. 2005;4(2):187-94. (Pubitemid 40726883)
34. Söllner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer. 2000;89(4):873-80. (Pubitemid 30658588)
35. Adler SR, Fosket JR. Disclosing complementary and alternativemedicine use in the medical encounter: a qualitative study in women with breast cancer. J Fam Pract. 1999;48:453-8. (Pubitemid 30491158)
36. Boon H, Westlake K, Stewart M, Gray R, Fleshner N, Gavin A, Brown JB, Goel V. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology. 2003;62(5):849-53. (Pubitemid 37421230)
37. Ohlén J, Balneaves LG, Bottorff JL, Brazier AS. The influence of significant others in complementary and alternative medicine decisions by cancer patients. Soc Sci Med. 2006;63(6):1625-36. (Pubitemid 44108357)
38. Evans M, Shaw A, Thompson EA, Falk S, Turton P, Thompson T, et al. Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med. 2007;7:25.
39. Bonevski B, Wilson A, Henry DA. An analysis of news media coverage of complementary and alternative medicine. PLoS One. 2008;3(6):e2406.
40. Mercurio R, Eliott JA. Trick or treat? Australian newspaper portrayal of complementary and alternative medicine for the treatment of cancer. Support Care Cancer. Epub 2009: Nov 27.
41. Broom A, Tovey P. Therapeutic pluralism? Evidence, power and legitimacy in UK cancer services. Sociol Health Illn. 2007;29(4):551-69.
42. Eng J, Ramsum D, Verhoef M, Guns E, Davison J, Gallagher R. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther. 2005;2(3):212-6.
43. Hann D, Baker F, Denniston M, Entrekin N. Long-term breast cancer survivors' use of complementary therapies: perceived impact on recovery and prevention of recurrence. Integr Cancer Ther. 2005,4(1):14-20.
44. Ernst E. The role of complementary and alternative medicine in cancer, Lancet Oncol. 2000;1:176-80.
45. Robinson A, McGrail MR. Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med. 2004;12(2-3):90-8. (Pubitemid 39618835)
46. Ernst E. A primer of complementary and alternative medicine commonly used by cancer patients. Med J Aust. 2001;174:88-92. (Pubitemid 32094133)
47. Schraub S. Unproven methods in cancer: a worldwide problem, Support Care Cancer. 2000;8:10-5. (Pubitemid 30096539)
48. Risberg T, Lund E, Wist E, Kaasa S, Wilsgaard T. Cancer patients use of non-proven therapy: a 5-year follow-up study. J Clin Oncol. 1998;16:6-12. (Pubitemid 28041572)
49. Ernst E. Complementary cancer treatments: hope or hazard? Clin Oncol (R Coll Radiol). 1995;7(4):259-63.
50. Deng G, Cassileth BR. Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA Cancer J Clin. 2005;55(2):109-16. (Pubitemid 40372905)
51. Devine EC, Westlake SK. The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies. Oncol Nurs Forum. 1995;22(9):1369-81.
52. Joske DJ, Rao A, Kristjanson L. Critical review of complementary therapies in haemato-oncology. Intern Med J. 2006;36(9):579-86. (Pubitemid 44179833)
53. Newell SA, Sanson-Fisher RW, Savolainen NJ. Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. J Natl Cancer Inst. 2002;94(8):558-84. (Pubitemid 34498644)
54. Seely D, Oneschuk D. Interactions of natural health products with biomedical cancer treatments. Curr Oncol. 2008;15(Suppl 2):S81-6.
55. O'Beirne M, Verhoef M, Paluck E, Herbert C. Complementary therapy use by cancer patients. Physicians' perceptions, attitudes, and ideas. Can Fam Physician. 2004;50:882-8.
56. Eisenberg DM, Kessler RC, Van Rompay MI, Kaptchuk TJ, Wilkey SA, Appel S, Davis RB. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med. 2001;135(5):344-51. (Pubitemid 32823241)
57. Cassileth B, Yeung KS, Gubili J. Herbs and other botanicals in cancer patient care, Curr Treat Options Oncol. 2008;9(2-3):109-16.
58. Shord SS, Shah K, Lukose A. Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals, Integr Cancer Ther. 2009;8(3):208-27.
59. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst. 2008;100(11):773-83.
60. Pirri C. An evidence-based systematic review of complementary and alternative medicine (CAM): recommendations concerning the efficacy and safety of CAM use by adult cancer patients. In: Olver IO, Robotin MC, editors. Perspectives of complementary and alternative medicines (CAMS). Sydney: Imperial College Press. In press 2011.
61. Bagenal FS, Easton DF, Harris E, Chilvers CE, McElwain TJ. Survival of patients with breast cancer attending Bristol Cancer Help Centre. Lancet. 1990;336(8715):606-10. (Pubitemid 20296927)
62. Cassileth BR, Lusk EJ, Guerry D, Blake AD, Walsh WP, Kascius L, Schultz DJ. Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med. 1991;324(17):1180-5.
63. Robotin MC, Penman AG. Integrating complementary therapies into mainstream cancer care: which way forward? Med J Aust. 2006;185(7):377-9. (Pubitemid 44540800)
64. Hlubocky FJ, Retain MJ, Wen M, Daugherty CK. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. J Clin Oncol. 2007;25(5):548-54. (Pubitemid 350002962)
65. Dy GK, Bekele L, Hanson LJ, Furth A, Mandrekar S, Sloan JA, Adjei AA. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol. 2004;22(23):4810-5.
66. Cassileth B, Heitzer M, Gubili J. Integrative oncology: complementary therapies in cancer care. Cancer Chemother Rev. 2008;3(4):204-11.
67. Munshi A, Ni LH, Tiwana MS. Complementary and alternative medicine in present day oncology care: promises and pitfalls. Jpn J Clin Oncol. 2008;38(8):512-20.
68. Lotfi-Jam K, Carey M, Jefford M, Schofield P, Charleson C, Aranda S. Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J Clin Oncol. 2008;26(34):5618-29.
69. Clinical Oncological Society of Australia (COSA) [Internet]. Complementary and alternative medicine (CAM): setting an Australian research agenda. 2007 Nov [cited 2010 Jun 23]. Available from: http://tinyurl.com/ 34tepj7.
70. The National Institute of Complementary Medicine (NICM) [Internet]. C2010 [cited 2010 Jun 24]. Available from: http://www.nicm.edu.au/.
71. Association of American Medical Colleges. In: National Institute of Complementary Medicine (NICM), editor. Facts and statistics: NICM; 2008 [updated 2009 Jan 22; cited 2010 Jun 24]. Available from: http://www.nicm.edu.au/ content/view/65/36/.
72. American Hospital Association (AHA) [Internet]. Latest survey shows more hospitals offering complementary and alternative medicine services: AHA; 2008 Sep 15 [cited 2010 Jun 25]. Available from: http://www.aha.org/aha/press- release/2008/080915-pr-cam.html.
73. Bulsara C, Ward A, Joske D. Haematological cancer patients: achieving a sense of empowerment by use of strategies to control illness. J Clin Nurs. 2004;13(2):251-8. (Pubitemid 38184157)
74. Lowenthal RM. Integrative oncology in Australia. J Soc Integr Oncol. 2006;4(2):82-5.
75. Joske DJL, Petterson AS, Phillips M. Psychosocial support: providing complementary therapies for cancer patients in a WA teaching hospital, results from SolarisCare's eight years of experience. WA Cancer Research Symposium 2009: Proceedings of the 3rd WA Cancer Research Symposium 'Advancing Cancer Research in WA; 2009 Dec 3; Fremantle, Australia. West Perth: Cancer Council Western Australia; 2009 [cited 2010 Jan 15]. Available from: http://solariscare.org.au/ cache/fcfd78c2f4fe0d4162021957e7952b87/CCOF-WA-Research-Symposium-Psychosocial- Support.pdf.
76. O'Callaghan C, McDermott F. Music therapy's relevance in a cancer hospital researched through a constructivist lens. J Music Ther. 2004;41(2):151-85. (Pubitemid 39202989)
77. The Olivia-Newton John Cancer Centre [Internet]. Heidelberg: Austin Health; C2004 [cited 2010 Jun 24]. Available from: http://www.oliviaappeal.com/ help/default.asp.
78. McEwen J. What does TGA approval of medicines mean? Aust Prescriber. 2004;27:156-8.
79. Newell S, Sanson-Fisher RW. Australian oncologists' self-reported knowledge and attitudes about non-traditional therapies used by cancer patients. Med J Aust. 2000;172(3):110-3. (Pubitemid 30111109)
80. Crocetti E, Crotti N, Montella M, Musso M. Complementary medicine and oncologists' attitudes: a survey in Italy. Tumori. 1996;82:539-42. (Pubitemid 27120797)
81. Bourgeault IL. Physicians' attitudes towards patients' use of alternative cancer therapies. Can Med Assoc J. 1996;155:1679-85. (Pubitemid 27022833)
82. Giveon SM, Liberman N, Klang S, Kahan E. A survey of primary care physicians' perceptions of their patients' use of complementary medicine. Complement Ther Med. 2003;11:254-60. (Pubitemid 38292338)
83. Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncology. 2002;11(3):212-20. (Pubitemid 34618586)
84. Hann DM, Baker F, Denniston MM. Oncology professionals' communication with cancer patients about complementary therapy: a survey. Complement Ther Med. 2003;11(3):184-90.
85. Roberts C, Benjamin H, Chen L, Gavigan M, Gesme D, McCarthy P, et al. Assessing communication between oncology professionals and their patients. J Cancer Educ. 2005;20(2):113-8. (Pubitemid 41061255)
86. Angell M, Kassirer JP. Alternative medicine the risks of untested and unregulated remedies. N Engl J Med. 1998;339(12):839-41. (Pubitemid 28447460)
87. Studdert DM, Eisenberg DM, Miller FH, Curto DA, Kaptchuk TJ, Brennan TA. Medical malpractice implications of alternative medicine, JAMA. 1998;280(18):1610-5. (Pubitemid 28520651)
88. Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med. 2002;137(11):889-903. (Pubitemid 35416625)
89. Eisenberg D. Advising patients who seek alternative and complementary medical therapies. Annal Intern Med. 1997;127:61-9. (Pubitemid 27283905)
90. Epstein RM, Street RL Jr. Patient-centered communication in cancer care: promoting healing and reducing suffering. NIH Publication No. 07-6225. Bethesda: National Cancer Institute; 2007 [cited 2010 Jun 24). Available from: http://outcomes.cancer.gov/areas/pcc/communication/monograph.html.
91. Burstein H. Discussing complementary therapies with cancer patients: what should we be talking about? J Clin Oncol. 2000;18:2501-4.
92. Zollman C, Vickers A. ABC of complementary medicine: complementary medicine and the doctor. Br Med J. 1999;319:1558-61.
93. Mackenzie G, Parkinson M, Lakhani A, Pannekoek H. Issues that influence patient/physician discussion of complementary therapies. Patient Educ Couns. 1999;38:155-9. (Pubitemid 29430208)
94. Frenkel M, Ben-Arye E, Baldwin CD, Sierpina V. Approach to communicating with patients about the use of nutritional supplements in cancer care. South Med J. 2005;98:289-94. (Pubitemid 40381706)
95. Steyer TE. Complementary and alternative medicine: a primer, Fam Pract Manag. 2001;8(3):37-42.
96. Schofield P, Diggens J, Charleson C, Marigliani R, Jefford M. Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns. 2010;79(2):143-51.